Is Omkar Pharmachem Ltd debt-free?

Yes, Omkar Pharmachem Ltd is debt-free with a debt-to-equity ratio of 0.01.

Home

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd Financials

Omkar Pharmachem Ltd Financial Statement

Omkar Pharmachem Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2025	Jun 2025	Mar 2025
Revenue	0.14	0.14	0.14
Operating Expense	0.07	0.10	0.07
Net Profit	0.05	0.03	-0.02
Net Profit Margin	35.71	21.43	-14.29
Earning Per Share	0.05	0.03	-0.02
EBIDTA	0.07	0.04	0.07
Effective Tax Rate	28.57	25	100

Particulars	Sep 2025
Revenue	0.14
Operating Expense	0.07
Net Profit	0.05
Net Profit Margin	35.71
Earning Per Share	0.05
EBIDTA	0.07
Effective Tax Rate	28.57

Omkar Pharmachem Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	0.54	0.54	0.54
Operating Expenses Annual	0.25	0.26	0.23
Operating Profit Annual	0.29	0.29	0.31
Interest Annual	0.02	0.03	0.05
Depreciation	0.01	0.00	0.00
Net Profit Annual	0.20	0.19	0.20
Tax Annual	0.07	0.06	0.07

Particulars	Mar 2025
Total Revenue Annual	0.54
Operating Expenses Annual	0.25
Operating Profit Annual	0.29
Interest Annual	0.02
Depreciation	0.01
Net Profit Annual	0.20
Tax Annual	0.07

Omkar Pharmachem Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	0.07	0.13	0.21
Cash Flow from Operations	0.24	0.30	0.28
Cash Flow from Investing	TBA	-0.01	TBA
Cash Flow from Financing	-0.20	-0.35	-0.35
Cash Flow at the End	0.11	0.07	0.13

Particulars	Mar 2025
Cash Flow at the Beginning	0.07
Cash Flow from Operations	0.24
Cash Flow from Investing	TBA
Cash Flow from Financing	-0.20
Cash Flow at the End	0.11

Omkar Pharmachem Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	55.56	53.70	59.26
PBIT Margin (%)	53.70	53.70	59.26
PBT Margin (%)	-2,631.49	-1,674.08	-1,125.93
Net PROFIT Margin (%)	37.04	35.19	37.04
Return On Networth / Equity (%)	1.98	1.88	1.98
Return On Networth /Employed (%)	2.82	2.66	2.95
Return On Assets (%)	2.22	2.11	2.22
Total Debt / Equity (X)	0.02	0.05	0.09
Asset Turnover Ratio (%)	0.06	0.06	0.06

Particulars	Mar 2025
PBDIT Margin (%)	55.56
PBIT Margin (%)	53.70
PBT Margin (%)	-2,631.49
Net PROFIT Margin (%)	37.04
Return On Networth / Equity (%)	1.98
Return On Networth /Employed (%)	2.82
Return On Assets (%)	2.22
Total Debt / Equity (X)	0.02
Asset Turnover Ratio (%)	0.06

Omkar Pharmachem Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	0.01	0.01	0.00
Total Current Assets Annual	0.27	0.18	0.26
Non Current Assets Annual	9.34	9.41	9.47
Total Shareholders Funds Annual	9.43	9.23	9.04
Total Assets Annual	9.60	9.59	9.73

Particulars	Mar 2025
Fixed Assets Annual	0.01
Total Current Assets Annual	0.27
Non Current Assets Annual	9.34
Total Shareholders Funds Annual	9.43
Total Assets Annual	9.60

Omkar Pharmachem Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Omkar Pharmachem Ltd Financials

As of Dec 15, 2025, Omkar Pharmachem Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Omkar Pharmachem Ltd is with a debt-to-equity ratio of 0.01.

In FY 2024 , Omkar Pharmachem Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Omkar Pharmachem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -100.0% and NaN% annually, respectively..

Omkar Pharmachem Ltd's current PE ratio is .

Omkar Pharmachem Ltd's ROCE averaged 3.1% from the FY ending March 2023 to 2025, with a median of 3.0%. It peaked at 3.2% in March 2023, reflecting strong capital efficiency over the period..

Omkar Pharmachem Ltd's latest EBIT is Rs. 0.29 Cr, surpassing the average EBIT of Rs. 0.29 Cr over the 5 years..